CAS: 1621999-82-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CC-90003 REF: TM-T14894CAS: 1621999-82-3 | 99.14% | 46.00 €~541.00 € | Mon 13 Jan 25 |
 | CC-90003 REF: IN-DA01EO7DCAS: 1621999-82-3 | 99% | To inquire | Mon 13 Jan 25 |
 | N-(2-((2-((2-Methoxy-5-methylpyridin-4-yl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)-5-methylph REF: 54-BISN0236CAS: 1621999-82-3 | - - - | 138.00 €~1,199.00 € | Tue 21 Jan 25 |
 | CC-90003 REF: 3D-WPC99982CAS: 1621999-82-3 | Min. 95% | - - - | Discontinued product |
CC-90003
CAS:1621999-82-3
CC-90003 is a selective inhibitor of ERK 1/2. It has antitumor activity.
Formula:
C22H21F3N6O2
Purity:
99.14%
Color and Shape:
Solid
Molecular weight:
458.44
Ref: TM-T14894
| 1mg | 46.00 € | ||
| 5mg | 86.00 € | ||
| 10mg | 132.00 € | ||
| 25mg | 255.00 € | ||
| 50mg | 362.00 € | ||
| 100mg | 541.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
N-(2-((2-((2-Methoxy-5-methylpyridin-4-yl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)-5-methylph
CAS:1621999-82-3
Molecular weight:
458.44g/mol
Ref: 54-BISN0236
| 10mg | 138.00 € | ||
| 25mg | 260.00 € | ||
| 50mg | 418.00 € | ||
| 100mg | 697.00 € | ||
| 250mg | 1,199.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
CC-90003
CAS:1621999-82-3
CC-90003 is a clinical-stage, small molecule inhibitor of the extracellular signal regulated kinase (ERK) pathway. …
Formula:
C22H21F3N6O2
Purity:
Min. 95%
Molecular weight:
458.44 g/mol
Ref: 3D-WPC99982
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
